Jing Tian

Jing Tian is a Postdoctoral Researcher at the Du Lab within the Department of Pharmacology & Toxicology at the School of Pharmacy, University of Kansas. Their research focuses on metabolism-related molecular mechanisms of neurodegeneration in Alzheimer’s Disease and developing novel therapeutic targets for Alzheimer’s patients.

• Ph.D., Molecular and Cell Biology, The University of Texas at Dallas (2020)
• M.S., Molecular and Cell Biology, University of Texas at Dallas (2015)
• B.S., Biotechnology, Northwest University, Shaanxi, China (2000)

Research interests span neurodegenerative diseases, molecular biology, and metabolic pathways, with a specific emphasis on understanding and targeting cellular mechanisms in Alzheimer’s Disease. The work bridges neuroscience and pharmacology to identify therapeutic interventions.